491 related articles for article (PubMed ID: 30244071)
1. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
2. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
[TBL] [Abstract][Full Text] [Related]
3. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U
Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the alpha1beta1 isoform of the Na, K-ATPase by 8-methoxycoumestrol without positive inotropic effect in human myocardium--novel aspects of cardiac glycoside pharmacology.
Potter T; Hauck C; Pôças ES; Diedrichs H; Adam C; Reuter H; Wittwer T; Wahlers T; da Silva AJ; Costa PR; Noël F; Müller-Ehmsen J
J Cardiovasc Pharmacol; 2009 Jul; 54(1):10-5. PubMed ID: 19487957
[TBL] [Abstract][Full Text] [Related]
6. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
Venter PA; Naudé RJ; Oelofsen W; Swan GE
Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
[TBL] [Abstract][Full Text] [Related]
7. Interaction of palytoxin and cardiac glycosides on erythrocyte membrane and (Na+ + K+) ATPase.
Ozaki H; Nagase H; Urakawa N
Eur J Biochem; 1985 Oct; 152(2):475-80. PubMed ID: 2865137
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
[TBL] [Abstract][Full Text] [Related]
9. Conformational states of the pig kidney Na
Azalim P; do Monte FM; Rendeiro MM; Liu X; O'Doherty GA; Fontes CF; Leitão SG; Quintas LEM; Noël F
Biochem Pharmacol; 2020 Jan; 171():113679. PubMed ID: 31669257
[TBL] [Abstract][Full Text] [Related]
10. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
11. Selectivity of digitalis glycosides for isoforms of human Na,K-ATPase.
Katz A; Lifshitz Y; Bab-Dinitz E; Kapri-Pardes E; Goldshleger R; Tal DM; Karlish SJ
J Biol Chem; 2010 Jun; 285(25):19582-92. PubMed ID: 20388710
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
13. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase.
Brown L; Erdmann E; Thomas R
Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008
[TBL] [Abstract][Full Text] [Related]
14. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
Gupta RS; Chopra A
J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
[TBL] [Abstract][Full Text] [Related]
15. Cardiotonic steroids as potential Na
Patel CN; Kumar SP; Modi KM; Soni MN; Modi NR; Pandya HA
J Recept Signal Transduct Res; 2019 Jun; 39(3):226-234. PubMed ID: 31509043
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
Chopra A; Gupta RS
J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
[TBL] [Abstract][Full Text] [Related]
17. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
18. Steroid-like compounds in Chinese medicines promote blood circulation via inhibition of Na+/K+ -ATPase.
Chen RJ; Chung TY; Li FY; Yang WH; Jinn TR; Tzen JT
Acta Pharmacol Sin; 2010 Jun; 31(6):696-702. PubMed ID: 20523340
[TBL] [Abstract][Full Text] [Related]
19. Ouabain interactions with the H5-H6 hairpin of the Na,K-ATPase reveal a possible inhibition mechanism via the cation binding domain.
Palasis M; Kuntzweiler TA; Argüello JM; Lingrel JB
J Biol Chem; 1996 Jun; 271(24):14176-82. PubMed ID: 8662895
[TBL] [Abstract][Full Text] [Related]
20. Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex.
Laursen M; Gregersen JL; Yatime L; Nissen P; Fedosova NU
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1755-60. PubMed ID: 25624492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]